AbbVie Market Cap 2010-2019 | ABBV

AbbVie market cap history and chart from 2010 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. AbbVie market cap as of May 21, 2019 is $118B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $118.000B $32.753B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $371.367B 16.84
Pfizer (PFE) United States $247.580B 13.50
Merck (MRK) United States $212.675B 17.49
Novartis AG (NVS) Switzerland $189.443B 16.37
Novo Nordisk (NVO) Denmark $115.481B 19.21
Eli Lilly (LLY) United States $112.840B 20.94
Sanofi (SNY) France $103.910B 12.75
GlaxoSmithKline (GSK) United Kingdom $97.711B 12.39
AstraZeneca (AZN) United Kingdom $95.085B 10.94
Bristol-Myers Squibb (BMY) United States $75.750B 11.19